Funding for this research was provided by:
Agency for Clinical Innovation
Whitlam Joint Replacement Centre
Whitlam Orthopaedic Research Centre
Received: 19 March 2020
Accepted: 9 June 2020
First Online: 22 June 2020
Ethics approval and consent to participate
: The overarching QI study was approved by the South West Sydney Ethics Committee (LNR/18/LPOOL/128). As per our ethical approval and protocol, participants were provided with a Participant Information Sheet (in multiple languages) and were asked to provide verbal informed consent to be followed up after discharge. This was consistent with current procedures already in place at our hospital at the time; patients were already routinely followed-up by telephone after a few days following discharge by nursing staff and at 6-months by ACORN (the Arthroplasty Clinical Outcome Registry National) (ExternalRef removed). Written consent is not required by patients for either of these activities though they are informed. A record of who declined to participate in the follow-up was kept by the study chief investigator in an excel file that included patient screening and consent details.
: Not relevant.
: The authors declare that they have no competing interests.